Ambu A/S (LTS:0MJF)
kr 135.225 -0.875 (-0.64%) Market Cap: 36.39 Bil Enterprise Value: 36.63 Bil PE Ratio: 99.02 PB Ratio: 6.49 GF Score: 74/100

Ambu A/S at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 03:50PM GMT
Release Date Price: kr248.5 (+2.77%)
David James Adlington
JPMorgan Chase & Co, Research Division - Head of Medical Technology and Services Equity Research

Good afternoon. Good morning, everybody. This is David Adlington from the JPMorgan medtech team in Europe.

It's my pleasure to introduce Juan Jose Gonzalez from Ambu in a second. (Operator Instructions)

Jose, thanks for joining us today, and over to you for the presentation.

Juan Jose Gonzalez;S;CEO;Member of Executive Board
Ambu A

/-&

Thank you very much, David, and it's a pleasure to be with all of you. Let me just spend a few minutes talking about the market, who we are as a company, our performance last year and our outlook. And at the end, I think you are all going to be as excited as we are with the potential of Ambu.

So if we all go to Slide 3, let's start with the market. The single-use endoscopy market is considered one of the fastest-growing new markets in medtech. And just to give you a bit of context for the ones who are not familiar, endoscopy

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot